|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.95 USD | -4.82% |
|
+1.54% | -17.71% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
May 3 (Reuters) - Novavax Inc said on Monday it had expanded the late-stage study testing its COVID-19 vaccine candidate to include up to 3,000 adolescents aged 12 to 17. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.71% | 581M | |
| +1.12% | 43.84B | |
| +6.77% | 41.68B | |
| +45.26% | 41.25B | |
| -11.96% | 27.04B | |
| +6.01% | 25.53B | |
| -24.92% | 18.18B | |
| -3.63% | 12.29B | |
| +27.16% | 12.29B | |
| +7.30% | 11.15B |
NOVAVAX, INC. 
